Abrocitinib | Atopic Dermatitis | Q4 2022 |
Apixaban | Deep vein thrombosis | ✓ |
Azithromycin | Bacterial infection | ✓ |
Baloxavir Marboxil | Anti-flu virus | ✓ |
Bictegravir Sodium | HIV-1 infection | TBD |
Canagliflozin | Type 2 Diabetes | ✓ |
Ciprofloxacin HCL | Bacterial infection | ✓ |
Clarithromycin | Bacterial infection | ✓ |
Clascoterone | Acne Vulgaris | TBD |
Crisaborole | Atopic Dermatitis | Q2 2022 |
Dabigatran Etexilate Mesylate | anticoagulant | ✓ |
Elagolix Sodium | Pain caused by endometriosis | ✓ |
Eltrombopag Olamine | ITP&Aplastic anemia Thrombocytopenia | Q2 2022 |
Ezetimibe | Hyperlipidemia | ✓ |
LCZ696(Sacubitril+Valsartan) | Heart failure | ✓ |
Ledipasvir | Hepatitis C | ✓ |
Lenalidomide | Multiple Myeloma | ✓ |
Levetiracetam | Epilepsy | ✓ |
Niraparib Tosylate | Ovarian/Fallopian tube/primary peritoneal cancer | TBD |
Pomalidomide | Multiple Myeloma | ✓ |
Pregabalin | Diabetic Peripheral Neuropathic pain | ✓ |
Relugolix | Prostate cancer, uterus fibrosis | Q1 2023 |
Ribociclib | HR-positive, HER2-negative advanced or metastatic breast cancer | TBD |
Rimegepant (Sulfate) | Migraine | Q4 2022 |
Rivaroxaban | Deep venous thrombosis (DVT) | ✓ |
Rosuvastatin Calcium | Hypercholesterolemia | ✓ |
Ruxolitinib Phosphate | Atopic Dermatitis, Myelofibrosis | TBD |
Sitagliptin phosphate | Diabetes | ✓ |
Solifenacin | Overactive bladder symptoms | Q2 2022 |
Sugammadex sodium | Reversal of drug-induced neuromuscular block | ✓ |
Ticagrelor | Anticoagulant | ✓ |
Tofacitinib Citrate | Active psoriatic arthritis | ✓ |
Ubrogepant | Migraine | TBD |
Vildagliptin | Diabetes | TBD |
Velpatasvir | chronic Hepatitis C | ✓ |
Venetoclax | Chronic lymphocytic leukemia, Small lymphocytic leukemia | TBD |
Vericiguat | Heart failure | Q2 2023 |